These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21682577)

  • 1. Urinary lithogenesis risk tests: comparison of a commercial kit and a laboratory prototype test.
    Grases F; Costa-Bauzá A; Prieto RM; Arrabal M; De Haro T; Lancina JA; Barbuzano C; Colom S; Riera J; Perelló J; Isern B; Sanchis P; Conte A; Barragan F; Gomila I
    Scand J Urol Nephrol; 2011 Nov; 45(5):312-8. PubMed ID: 21682577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and physico-chemical urolithiasis parameters in the first morning urine.
    Serić V; Dutour-Sikirić M; Mihaljević I; Tucak-Zorić S; Bilić-Curcić I; Babić-Ivancić V
    Coll Antropol; 2009 Dec; 33 Suppl 2():85-92. PubMed ID: 20120404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of lithogenic risk in children based on a morning spot urine sample.
    Porowski T; Kirejczyk JK; Zoch-Zwierz W; Konstantynowicz J; Korzeniecka-Kozerska A; Motkowski R; Laube N
    J Urol; 2010 Nov; 184(5):2103-8. PubMed ID: 20850811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis.
    Pak CY; Peterson R; Poindexter JR
    J Urol; 2001 Feb; 165(2):378-81. PubMed ID: 11176377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extended metabolic diagnosis of urolithiasis].
    Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
    Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
    Hamid R; Robertson WG; Woodhouse CR
    BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urolithiasis: a link between stone formation and diabetes mellitus?
    Zimmerer T; Weiss C; Hammes HP; Braun C; Hesse A; Alken P; Knoll T
    Urol Int; 2009; 82(3):350-5. PubMed ID: 19440027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the two immunochromatographic methods for detecting urine and serum IgG antibodies to Helicobacter pylori and comparison of accuracy and clinical utility.
    Hu HM; Kuo CH; Lo YC; Wu MT; Wu IC; Lu CY; Su YC; Yu FJ; Lee YC; Lin SR; Liu CS; Jan CM; Wang WM; Wu DC
    Hepatogastroenterology; 2007; 54(73):119-23. PubMed ID: 17419244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R; Czkwianianc E; Niedworok M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points.
    Lammers RL; Gibson S; Kovacs D; Sears W; Strachan G
    Ann Emerg Med; 2001 Nov; 38(5):505-12. PubMed ID: 11679861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity evaluation of in-house preparation kit, vaginal pH paper test combined amine tube test, for the simple diagnosis of bacterial vaginosis.
    Loyprasert-Thananimit S; Kuasuwan P; Nittayaboon K; Chotigeat W; Chandeying N; Chandeying V
    J Med Assoc Thai; 2012 Jun; 95(6):747-51. PubMed ID: 22774616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular heterogeneity of alpha 1-antitrypsin in the urine of the urolithiasis].
    Kawakami Y; Toyoda E; Kubota R; Kanamori K; Shimomura H; Sakai N; Shiba K
    Rinsho Byori; 2013 Jan; 61(1):25-31. PubMed ID: 23672078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.